Dexamfetamine

BNF:: 4.4
Status:: Amber
Decision Date:: None

Comments

See shared care guideline for drugs used in the management of ADHD in adults and children

3rd line drug choice

Amber Drug Classifications

1: Requiring specialist assessment to enable patient selection and initiation of treatment
3: Requiring short or medium term specialist monitoring of toxicity